Oligonucleotide therapies for nonalcoholic steatohepatitis

Nonalcoholic steatohepatitis (NASH) represents a severe disease subtype of nonalcoholic fatty liver disease (NAFLD) that is thought to be highly associated with systemic metabolic abnormalities. It is characterized by a series of substantial liver damage, including hepatocellular steatosis, inflamma...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Sixu Li, Feng Xiong, Songbo Zhang, Jinghua Liu, Guangping Gao, Jun Xie, Yi Wang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2024-06-01
Edice:	Molecular Therapy: Nucleic Acids
Témata:	MT: Oligonucleotides: Therapies and Applications NASH NAFLD RNAi ASO siRNA
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2162253124000714
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!